BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 6234759)

  • 21. Metabolism of glycolipids: the role of glycolipid-binding proteins in the function and pathobiochemistry of lysosomes.
    Sandhoff K; van Echten G; Schröder M; Schnabel D; Suzuki K
    Biochem Soc Trans; 1992 Aug; 20(3):695-9. PubMed ID: 1426613
    [No Abstract]   [Full Text] [Related]  

  • 22. Interaction of activating protein and surfactants with human liver hexosaminidase A and GM2 ganglioside.
    Hechtman P; Kachra Z
    Biochem J; 1980 Mar; 185(3):583-91. PubMed ID: 7387624
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Intracellular trafficking of glycosphingolipids: role of sphingolipid activator proteins in the topology of endocytosis and lysosomal digestion.
    Sandhoff K; Klein A
    FEBS Lett; 1994 Jun; 346(1):103-7. PubMed ID: 8206147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel glycosphingolipid-degrading enzyme cleaves the linkage between the oligosaccharide and ceramide of neutral and acidic glycosphingolipids.
    Ito M; Yamagata T
    J Biol Chem; 1986 Oct; 261(30):14278-82. PubMed ID: 3771534
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemistry of glycosphingolipid degradation.
    Sandhoff K; Kolter T
    Clin Chim Acta; 1997 Oct; 266(1):51-61. PubMed ID: 9435988
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biosynthesis of the sulfatide/GM1 activator protein (SAP-1) in control and mutant cultured skin fibroblasts.
    Fujibayashi S; Wenger DA
    Biochim Biophys Acta; 1986 Feb; 875(3):554-62. PubMed ID: 3081038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Quantification of mRNAs encoding proteins of the glycosphingolipid catabolism in mouse models of GM2 gangliosidoses and sphingolipid activator protein precursor (prosaposin) deficiency.
    Potratz A; Hüttler S; Bierfreund U; Proia RL; Suzuki K; Sandhoff K
    Biochim Biophys Acta; 2000 Nov; 1502(3):391-7. PubMed ID: 11068181
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurochemistry of the mucopolysaccharidoses: brain glycosaminoglycans, lipids and lysosomal enzymes in mucopolysaccharidosis type III B (alpha-N-acetylglucosaminidase deficiency).
    Constantopoulos G; Eiben RM; Schafer IA
    J Neurochem; 1978 Nov; 31(5):1215-22. PubMed ID: 100580
    [No Abstract]   [Full Text] [Related]  

  • 29. Glycosphingolipid specificity of the human sulfatide activator protein.
    Vogel A; Schwarzmann G; Sandhoff K
    Eur J Biochem; 1991 Sep; 200(2):591-7. PubMed ID: 1889421
    [TBL] [Abstract][Full Text] [Related]  

  • 30. My journey into the world of sphingolipids and sphingolipidoses.
    Sandhoff K
    Proc Jpn Acad Ser B Phys Biol Sci; 2012; 88(10):554-82. PubMed ID: 23229750
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The specificity of human N-acetyl-beta-D-hexosaminidases towards glycosphincolipids is determined by an activator protein.
    Conzelmann E; Sandhoff K
    Adv Exp Med Biol; 1980; 125():295-306. PubMed ID: 6444774
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Binding of GM1 ganglioside to a synthetic peptide derived from the lysosomal sphingolipid activator protein saposin B.
    Champagne MJ; Lamontagne S; Potier M
    FEBS Lett; 1994 Aug; 349(3):439-41. PubMed ID: 8050611
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Binding of GM1-ganglioside to a synthetic peptide derived from the lysosomal sphingolipid-activator-protein saposin B.
    Champagne MJ; Lamontagne S; Potier M
    FEBS Lett; 1994 Jun; 347(2-3):265-7. PubMed ID: 8034015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activator proteins for lysosomal glycolipid hydrolysis.
    Conzelmann E; Sandhoff K
    Methods Biochem Anal; 1987; 32():1-23. PubMed ID: 3553853
    [No Abstract]   [Full Text] [Related]  

  • 35. [Lysosomal glycosidase activity in cultured human fibroblasts].
    Beliaeva ID; Ivleva TS; Vidershaĭn GIa
    Biull Eksp Biol Med; 1984 Nov; 98(11):550-3. PubMed ID: 6239662
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sphingolipid metabolism. Sphingoid analogs, sphingolipid activator proteins, and the pathology of the cell.
    Sandhoff K; Kolter T; Van Echten-Deckert G
    Ann N Y Acad Sci; 1998 Jun; 845():139-51. PubMed ID: 9668348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hydrolysis of lactosylceramide by human galactosylceramidase and GM1-beta-galactosidase in a detergent-free system and its stimulation by sphingolipid activator proteins, sap-B and sap-C. Activator proteins stimulate lactosylceramide hydrolysis.
    Zschoche A; Fürst W; Schwarzmann G; Sanhoff K
    Eur J Biochem; 1994 May; 222(1):83-90. PubMed ID: 8200356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Secretion by mononuclear phagocytes of lysosomal hydrolases bearing ligands for the mannose-6-phosphate receptor system of fibroblasts: evidence for a second mechanism of spontaneous secretion?
    Jessup W; Dean RT
    Biochem Biophys Res Commun; 1982 Apr; 105(3):922-7. PubMed ID: 6284168
    [No Abstract]   [Full Text] [Related]  

  • 39. Sphingolipid activator proteins (SAPs) are stored together with glycosphingolipids in the infantile neuronal ceroid-lipofuscinosis (INCL).
    Tyynelä J; Baumann M; Henseler M; Sandhoff K; Haltia M
    Am J Med Genet; 1995 Jun; 57(2):294-7. PubMed ID: 7668348
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis of novel NBD-GM1 and NBD-GM2 for the transfer activity of GM2-activator protein by a FRET-based assay system.
    Schwarzmann G; Wendeler M; Sandhoff K
    Glycobiology; 2005 Dec; 15(12):1302-11. PubMed ID: 16079415
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.